Sanofi India Ltd
NSE:SANOFI

Watchlist Manager
Sanofi India Ltd Logo
Sanofi India Ltd
NSE:SANOFI
Watchlist
Price: 4 271 INR -1.37% Market Closed
Market Cap: 98.4B INR

Relative Value

The Relative Value of one SANOFI stock under the Base Case scenario is hidden INR. Compared to the current market price of 4 271 INR, Sanofi India Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SANOFI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
20
Median 3Y
6.3
Median 5Y
5.6
Industry
2.6
Forward
5.1
vs History
58
vs Industry
13
Median 3Y
30.4
Median 5Y
28.7
Industry
21.7
Forward
26
vs History
65
vs Industry
9
Median 3Y
42.2
Median 5Y
32.1
Industry
16.6
vs History
60
vs Industry
10
Median 3Y
47
Median 5Y
34.9
Industry
22.5
vs History
47
vs Industry
3
Median 3Y
16.6
Median 5Y
12.1
Industry
2.3
vs History
68
vs Industry
20
Median 3Y
6.2
Median 5Y
5.3
Industry
2.9
Forward
5
vs History
47
vs Industry
16
Median 3Y
11.1
Median 5Y
9.5
Industry
5.5
vs History
77
vs Industry
13
Median 3Y
22.9
Median 5Y
20.3
Industry
13.1
Forward
18
vs History
77
vs Industry
15
Median 3Y
24.5
Median 5Y
22.1
Industry
16.6
Forward
18.7
vs History
63
vs Industry
9
Median 3Y
41.3
Median 5Y
30.9
Industry
15.8
vs History
57
vs Industry
9
Median 3Y
45
Median 5Y
32.8
Industry
19.1
vs History
68
vs Industry
6
Median 3Y
17.1
Median 5Y
14.5
Industry
1.9

Multiples Across Competitors

SANOFI Competitors Multiples
Sanofi India Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Sanofi India Ltd
NSE:SANOFI
98.4B INR 5.1 27.6 18.3 19.8
US
Eli Lilly and Co
NYSE:LLY
943.6B USD 15.9 51.2 34.5 36.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
485.1B USD 5.3 19.3 15.8 20.5
CH
Roche Holding AG
SIX:ROG
252.8B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
210.6B GBP 4.8 29.8 108.2 158.3
CH
Novartis AG
SIX:NOVN
204.6B CHF 4.5 17.6 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
246.1B USD 3.8 12.9 9.2 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 9 10.4
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
146.5B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
IN
Sanofi India Ltd
NSE:SANOFI
Average P/E: 23.7
27.6
1%
27.6
US
Eli Lilly and Co
NYSE:LLY
51.2
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
17.6
17%
1
US
Merck & Co Inc
NYSE:MRK
12.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Sanofi India Ltd
NSE:SANOFI
Average EV/EBITDA: 399.3
18.3
6%
3.1
US
Eli Lilly and Co
NYSE:LLY
34.5
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.8
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Sanofi India Ltd
NSE:SANOFI
Average EV/EBIT: 1 709.4
19.8
6%
3.3
US
Eli Lilly and Co
NYSE:LLY
36.9
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
1%
10.4
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3